• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管细胞癌患者预后预测的不一致性:术前与术后视角。

Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.

机构信息

Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio.

Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan.

出版信息

J Surg Oncol. 2019 Nov;120(6):946-955. doi: 10.1002/jso.25671. Epub 2019 Aug 13.

DOI:10.1002/jso.25671
PMID:31410852
Abstract

BACKGROUND

The objective of the current study was to characterize patients with intrahepatic cholangiocarcinoma (ICC) undergoing curative-intent surgery with discordant preoperative and postoperative prediction scores and determine factors associated with prediction discrepancy.

METHODS

Patients who underwent hepatectomy for ICC between 1990 and 2016 were identified in a multi-institutional international database. Preoperative and postoperative prognostic models were designed and discordant prognostic scores were identified. A multivariable logistic regression analysis was completed to determined factors associated with score discordance.

RESULTS

Among 1149 patients, those who had concordant prediction scores were older (median age, 60 vs 56), and more likely to have a smaller median tumor size (6.0 vs 7.5 cm) (all P < .05). On multivariable logistic analysis, patients with higher neutrophil-lymphocyte ratio (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.09-1.19), higher CEA levels (OR, 1.25; 95% CI, 1.04-1.50), larger tumors (OR, 1.10; 95% CI, 1.04-1.15) and suspicious lymph nodes (OR, 2.05; 95% CI, 1.25-3.36) were more likely to have preoperative and postoperative score discordance. Older patients had decreased odds of having score discordance (OR, 0.98; 95% CI, 0.96-0.99). Patients with score discordance had worse overall survival compared with patients with concordant scores (median:15.9 vs 21.7 months, P < .05).

CONCLUSION

Score discordance may reflect an aggressive variant of ICC that would benefit from early integration of multidisciplinary treatment strategies.

摘要

背景

本研究的目的是对接受根治性手术的肝内胆管细胞癌(ICC)患者进行特征分析,这些患者的术前和术后预测评分存在差异,并确定与预测差异相关的因素。

方法

在一个多机构国际数据库中,确定了 1990 年至 2016 年间接受肝切除术治疗 ICC 的患者。设计了术前和术后预测模型,并确定了不一致的预测评分。采用多变量逻辑回归分析确定与评分差异相关的因素。

结果

在 1149 例患者中,具有一致预测评分的患者年龄更大(中位年龄为 60 岁比 56 岁),且肿瘤中位直径更小(6.0 cm 比 7.5 cm)(均 P <.05)。多变量逻辑回归分析显示,中性粒细胞与淋巴细胞比值较高(比值比 [OR],1.14;95%置信区间 [CI],1.09-1.19)、CEA 水平较高(OR,1.25;95% CI,1.04-1.50)、肿瘤较大(OR,1.10;95% CI,1.04-1.15)和可疑淋巴结(OR,2.05;95% CI,1.25-3.36)的患者更有可能出现术前和术后评分不一致。年龄较大的患者发生评分不一致的可能性降低(OR,0.98;95% CI,0.96-0.99)。与评分一致的患者相比,评分不一致的患者总生存率较差(中位数:15.9 个月比 21.7 个月,P <.05)。

结论

评分不一致可能反映 ICC 的侵袭性变异,这将受益于多学科治疗策略的早期整合。

相似文献

1
Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.肝内胆管细胞癌患者预后预测的不一致性:术前与术后视角。
J Surg Oncol. 2019 Nov;120(6):946-955. doi: 10.1002/jso.25671. Epub 2019 Aug 13.
2
Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection.术前预后营养指数可预测肝内胆管癌患者根治性切除术后的生存情况。
J Surg Oncol. 2018 Sep;118(3):422-430. doi: 10.1002/jso.25140. Epub 2018 Aug 6.
3
Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.术前淋巴结肿大对肝内胆管癌的预后影响:九州肝脏外科学术研究组的多机构研究
Ann Surg Oncol. 2015 Jul;22(7):2269-78. doi: 10.1245/s10434-014-4239-8. Epub 2015 Jan 13.
4
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.术前风险评分与肝内胆管细胞癌肝切除术后长期预后的预测。
J Am Coll Surg. 2018 Apr;226(4):393-403. doi: 10.1016/j.jamcollsurg.2017.12.011. Epub 2017 Dec 21.
5
Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.根治性切除术后肝内胆管细胞癌的复发模式和时间进程。
Ann Surg Oncol. 2019 Aug;26(8):2549-2557. doi: 10.1245/s10434-019-07353-4. Epub 2019 Apr 24.
6
Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.发热型肝内胆管细胞癌患者的临床特征及预后因素:倾向评分匹配分析。
Oncologist. 2019 Jul;24(7):997-1007. doi: 10.1634/theoncologist.2018-0268. Epub 2019 Mar 25.
7
A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.一种新的预后评分系统,利用术前可得因素预测肝门周围胆管癌手术切除后的生存情况。
Surgery. 2016 Mar;159(3):842-51. doi: 10.1016/j.surg.2015.10.027. Epub 2015 Dec 10.
8
Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.术前标准识别肝内胆管细胞癌淋巴结转移的低危人群。
J Hepatobiliary Pancreat Sci. 2018 Jun;25(6):299-307. doi: 10.1002/jhbp.552. Epub 2018 May 22.
9
Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.实验室风险评分(LabScore)的建立与验证:用于预测肝内胆管细胞癌切除术后的结局。
J Am Coll Surg. 2020 Apr;230(4):381-391.e2. doi: 10.1016/j.jamcollsurg.2019.12.025. Epub 2020 Jan 31.
10
The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.术前化疗治疗对手术治疗的肝内胆管癌患者的影响——一项多机构分析。
J Surg Oncol. 2017 Mar;115(3):312-318. doi: 10.1002/jso.24524. Epub 2017 Jan 20.

引用本文的文献

1
Association of Survival with Radiologic-Pathologic Discordance in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study Based on the Primary Liver Cancer Registry in Korea.肝细胞癌患者生存与放射学-病理学不一致的相关性:一项基于韩国原发性肝癌登记处的全国性队列研究
Gut Liver. 2025 Jul 15;19(4):602-616. doi: 10.5009/gnl240393. Epub 2025 Apr 1.
2
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma.肝内胆管癌的新辅助治疗和辅助治疗
J Clin Transl Hepatol. 2022 Jun 28;10(3):553-563. doi: 10.14218/JCTH.2021.00250. Epub 2022 Jan 4.
3
Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network.
利用长链非编码RNA相关的竞争性内源RNA网络鉴定肝内胆管癌的预后因素
Cancer Cell Int. 2020 Jul 16;20:315. doi: 10.1186/s12935-020-01388-4. eCollection 2020.